Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 3 » Issue 1

Optimizing economic outcomes in the management of COPD

Authors Dal Negro R

Published 7 March 2008 Volume 2008:3(1) Pages 1—10


Roberto Dal Negro

Lung Dept., Orlandi General Hospital, Bussolengo, Verona Italy

Abstract: Attention to COPD is increasing worldwide because its high prevalence, morbidity, and mortality present a challenging problem for all healthcare systems. The burden of COPD, which is usually measured in terms of progressive lung function decline, impact on patients’ symptoms, patient’s disability, and quality of life, together with the corresponding use of health care resources, is still a major aspect of the disease. Recommendations to treat COPD according to the most accepted guidelines have expanded in recent years even though COPD still remains unacceptably under-diagnosed and under-treated worldwide. Obviously, more severe degrees of COPD receive major attention both in terms of monitoring of clinical outcomes and of assessing the economic value of therapeutic interventions. The role of different strategies against COPD should be valued on the basis of their effectiveness in outcome optimization, which primarily depends on the efficacy of prevention activities and of early diagnosis programs. It is generally agreed that the main proportion of COPD burden still depends on the clinically uncontrolled disease and on its high exacerbation rate, which frequently leads to the patient hospitalization. In COPD, the effects of guideline recommendations have been only sporadically investigated in pharmaoeconomic terms, even though symptoms and disability have declined substantially; the corresponding improvement in quality of life, and a significant decrease in both direct and indirect costs have been proved to depend on appropriate rehabilitative and pharmacological long-term treatment of the disease. At present, more precise indices and more fitting outcomes are continuously sought and found in order to assess more effective strategies for controlling COPD.

Keywords: COPD, economic outcomes of COPD, COPD burden, COPD pharmacoeconomics

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Other articles by this author:

Survey on attitudes of Italian pediatricians toward cough

Zanasi A, Morcaldi L, Cazzato S, Mazzolini M, Lecchi M, Morselli-Labate AM, Mastroroberto M, Dal Negro RW

ClinicoEconomics and Outcomes Research 2017, 9:189-199

Published Date: 16 March 2017

Costs of illness analysis in Italian patients with chronic obstructive pulmonary disease (COPD): an update

Dal Negro RW, Bonadiman L, Turco P, Tognella S, Iannazzo S

ClinicoEconomics and Outcomes Research 2015, 7:153-159

Published Date: 16 March 2015

Readers of this article also read:

Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD

Wilson R, Anzueto A, Miravitlles M, Arvis P, Haverstock D, Trajanovic M, Sethi S

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:985-993

Published Date: 2 June 2015

Multimodal intervention improves fatigue and quality of life in subjects with progressive multiple sclerosis: a pilot study

Bisht B, Darling WG, Shivapour ET, Lutgendorf SK, Snetselaar LG, Chenard CA, Wahls TL

Degenerative Neurological and Neuromuscular Disease 2015, 5:19-35

Published Date: 27 February 2015

Pediatric cataract: challenges and future directions

Medsinge A, Nischal KK

Clinical Ophthalmology 2015, 9:77-90

Published Date: 7 January 2015

Isolated posterior uveal effusion: expanding the spectrum of the uveal effusion syndrome

Pautler SE, Browning DJ

Clinical Ophthalmology 2015, 9:43-49

Published Date: 30 December 2014

Nanotechnology versus stem cell engineering: in vitro comparison of neurite inductive potentials

Morano M, Wrobel S, Fregnan F, Ziv-Polat O, Shahar A, Ratzka A, Grothe C, Geuna S, Haastert-Talini K

International Journal of Nanomedicine 2014, 9:5289-5306

Published Date: 14 November 2014

Progressive disseminated histoplasmosis presenting with cachexia and hypercalcemia

Khasawneh FA, Ahmed S, Halloush RA

International Journal of General Medicine 2013, 6:79-83

Published Date: 27 February 2013

High rate of smoking in female patients with Mondor's disease in an outpatient clinic in Japan

Okumura T, Ohhira M, Nozu T

International Journal of General Medicine 2012, 5:735-738

Published Date: 4 September 2012

Main causes of death among Swedish women born 1914 and 1918: 32-year follow-up of the Population Study of Women in Gothenburg

Hange D, Sigurdsson JA, Björkelund C, Lapidus L, Bengtsson C

International Journal of General Medicine 2012, 5:597-601

Published Date: 12 July 2012

Mechanisms of atherothrombosis in chronic obstructive pulmonary disease

Filippo Luca Fimognari, Simone Scarlata, Maria Elisabetta Conte, Raffaele Antonelli Incalzi

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:89-96

Published Date: 7 March 2008